Helix logo in white and blue

Burden of disease and unmet needs

Drive informed decision-making and effective resource allocation through comprehensive understanding of disease burden and unmet need.

A VISFO "intelligence board" showing various components of the “Burden of disease and unmet need” offering in desktop view. Included are visualizations of "Disease burden", "Current vs unmet treatment needs" and "Treatment pathways and gaps in care". A mobile screen shows a "Disease burden" visualization as well as the available filters.

Definition

Criteria

Power your decision-making

with bespoke and intuitive intelligence boards

VISFO combines cutting-edge technology and deep subject matter expertise to de-silo data and enable confident decision-making. With all outputs housed in an agile, always-on delivery portal, you can quickly:

Visualize

Identify

  • The clinical, humanistic, social, and economic burden of disease
  • Diseases and patient populations characterized by a lack of suitable treatment options or inadequate treatments (limited by side effects, contraindications, or poor efficacy, for example)
A VISFO "intelligence board" showing various components of the “Burden of disease and unmet need” offering in desktop view. Included are visualizations of "Disease burden", "Current vs unmet treatment needs" and "Treatment pathways and gaps in care". A mobile screen shows a "Disease burden" visualization as well as the available filters.

Analyze

  • Treatment pathways, guidelines, the patient journey and critical areas of demand
  • The potential public health benefit of a new or improved treatment
  • Likely market size and opportunities for competitive differentiation

Continuously track the disease burden and unmet need in your therapy area with user-defined data updates.

Use cases

Champion increased funding for research into neglected diseases with high unmet needs

Select clinical trial endpoints that align with the most pressing unmet needs, improving trial relevance and outcome measures

Prioritize the development of novel therapies addressing identified unmet needs

Advocate for patient access to existing treatments and participate in discussions on drug pricing and reimbursement

Strengthen regulatory submissions with robust data demonstrating the need for new therapies

Provide evidence that your new therapy addresses key unmet needs to support your pricing and reimbursement negotiations with payers

Raise awareness about the impact of disease on patient lives and the need for better treatments

Enhance stakeholder engagement by presenting clear and compelling evidence of the burden of disease and unmet needs

Create educational resources for patients and healthcare providers based on burden of disease data

Delivered through Helix

Modular knowledge base

  • Interactive data visualizations for easy self-serve analysis and insight surfacing

  • Comprehensive opinion leader profiles for effective interaction planning and engagement

  • Multiple data export options for rapid insight sharing across your business

  • Customizable, modular knowledge bases with no user limits

A VISFO "Key Opinion Leader (KOL) intelligence board" displayed on both a desktop and mobile screen. The board includes an interactive KOL map, as well as the results of a KOL influence analysis."